Open Access

Complete Genome Sequence of a thermotolerant sporogenic lactic acid bacterium, Bacillus coagulans strain 36D1

  • Mun Su Rhee1,
  • Brélan E. Moritz1,
  • Gary Xie2, 3,
  • T. Glavina del Rio3,
  • E. Dalin3,
  • H. Tice3,
  • D. Bruce2, 3,
  • L. Goodwin2, 3,
  • O. Chertkov2, 3,
  • T. Brettin4,
  • C. Han2, 3,
  • C. Detter2, 3,
  • S. Pitluck3,
  • Miriam L. Land4,
  • Milind Patel1,
  • Mark Ou1,
  • Roberta Harbrucker1,
  • Lonnie O. Ingram1 and
  • K. T. Shanmugam1Email author
Standards in Genomic Sciences20115:5030331

DOI: 10.4056/sigs.2365342

Published: 31 December 2011

Abstract

Bacillus coagulans is a ubiquitous soil bacterium that grows at 50–55 °C and pH 5.0 and ferments various sugars that constitute plant biomass to L (+)-lactic acid. The ability of this sporogenic lactic acid bacterium to grow at 50–55 °C and pH 5.0 makes this organism an attractive microbial biocatalyst for production of optically pure lactic acid at industrial scale not only from glucose derived from cellulose but also from xylose, a major constituent of hemicellulose. This bacterium is also considered as a potential probiotic. Complete genome sequence of a representative strain, B. coagulans strain 36D1, is presented and discussed.

Keywords

Bacillus coagulans genome sequence lactic acid fermentation probiotics thermotolerant bacterium

Introduction

In addition to its use in food and cosmetics, lactic acid is increasingly used as a starting material for production of bio-based, renewable plastics [13]. Optically pure lactic acid required by the bioplastics industry is currently produced only by bacterial fermentation of sugars [3,4]. The main sugars currently used in such fermentations are glucose derived from corn starch or sucrose from sugar cane, sugar beets, etc. With increasing demand for renewable bio-based plastics, there is a shift away from food-based carbohydrates to non-food carbohydrates such as lignocellulosic biomass for lactic acid production [5,6]. Commercial fungal cellulases play a central role in the conversion of cellulose to glucose before fermentation to lactic acid and these enzymes function optimally at 50°C and pH 5.0 [710]. By matching the fungal enzyme activity optimum with that of the growth and fermentation optimum of the microbial biocatalyst, such as Bacillus coagulans, the amount of fungal cellulases required for simultaneous saccharification and fermentation (SSF) of cellulose to lactic acid can be reduced by a factor of three or higher compared to fermentation with lactic acid bacteria that grow optimally at temperatures below 40°C [9]. Since fungal enzymes represent a significant cost component of the overall process of biomass conversion to fuels and chemicals [11], reducing the enzyme loading during SSF of cellulose to lactic acid by B. coagulans is expected to lower the overall process cost and help the bioplastics industry compete with petroleum-based non-renewable plastics.

Bacillus coagulans belongs to a group of bacteria classified as sporogenic lactic acid bacteria [12]. These facultative anaerobes ferment pentoses, a component of hemicellulose, to L(+)-lactic acid as the major fermentation product reaching yields of 90% and titers close to 100 g/L in about 48 hours [13,14]. In this regard, B. coagulans differs from other lactic acid bacteria, such as Lactobacillus, Lactococcus, etc., in its ability to ferment pentose sugars to lactic acid through the pentose-phosphate pathway in contrast to the phosphoketolase pathway used by the lactic acid bacteria that yield an equimolar mixture of lactate and acetate [14]. Because of the thermotolerant, acid-tolerant and pentose fermentation characteristics, there is significant commercial interest in developing B. coagulans as a microbial biocatalyst for production of optically pure lactic acid as well as other fuels and chemicals. The higher operating temperature of B. coagulans is also expected to significantly reduce contamination of industrial fermentations that could lower product quality [15].

B. coagulans has been reported to function as a probiotic in animal trials and there is significant interest in the potential of this bacterium as a probiotic in humans [16]. These studies suggest that B. coagulans can readily achieve the GRAS (generally regarded as safe) status required for large scale industrial use. Genetic tools are being developed for manipulating B. coagulans, a genetically recalcitrant bacterium [17,18]. In order to fully explore the potential of B. coagulans as a microbial biocatalyst for production of fuels and chemicals, the entire genome of B. coagulans strain 36D1 was sequenced. Results from these experiments reveal that strain 36D1 has a single circular genome of 3,552,226 base pairs that encode 3,306 protein coding regions. Other characteristics of this bacterium, based on its genome composition, are presented and discussed.

Classification and features

B. coagulans was first isolated from coagulated milk by Hammer in 1915 [19]. Since then, several members of this group have been isolated from various sources [12,14]. B. coagulans strain 36D1 used in this study was isolated from a mud sample from an effluent stream of Old Faithful Geyser 1 near Calistoga, California, USA as an organism that can grow on xylose at 50°C and pH 5.0 both aerobically and anaerobically [14]. This bacterium is rod-shaped and produces endospore when cultured in nutrient broth (Fig. 1). Endospores are rarely observed when the bacterium was cultured in L-broth. Optimum temperature and pH for growth of strain 36D1 is 55°C and 5.5, respectively [10]. Corn steep liquor at 0.5% (w/v) provided the needed nutritional supplements for growth in mineral salts medium and the growth rate of the bacterium in that medium at 55°C was 1.67 h-1. The main fermentation product of the bacterium is L-lactate. Pentose fermentation increases the level of acetate, ethanol and formate in the medium compared to hexose fermentation [14]. Anaerobic cultures started with sparging of the medium with N2 require CO2 for growth. Other characteristics of the bacterium are listed in Table 1. B. coagulans strain 36D1 is deposited in the American Type Culture Collection (PTA-5827).
Figure 1.

Thin section electron micrographs of B. coagulans strain 36D1. Left: vegetative cell. Upper right: sporulating cell. Lower right: mature spore.

Table 1.

Classification and general features of Bacillus coagulans strain 36D1

MIGS ID

Property

Term

Evidence code

MIGS-2

Classification

Domain Bacteria

TAS [20]

 

Phylum Firmicutes

TAS [2123]

 

Class Bacilli

TAS [24,25]

 

Order Bacillales

TAS [26,27]

 

Family Bacillaceae

TAS [26,28]

 

Genus Bacillus

TAS [26,29,30]

MIGS-3

 

Species Bacillus coagulans

TAS [12,19,26]

  

Strain 36D1

 
 

Gram stain

Positive

IDA

 

Cell shape

Rods

IDA

 

Motility

Yes

IDA

 

Sporulation

Yes

IDA

 

Temperature range

Thermotolerant; 30 – 60 °C

TAS [10]

 

Optimum temperature

55 °C

TAS [10]

MIGS-22

Oxygen requirement

Facultative anaerobe

TAS [14]

 

Carbon source

Glucose, xylose, arabinose, galactose, maltose, fructose, cellobiose, yeast extract, peptone

IDA

 

Energy source

Organic carbon compounds

IDA

 

Terminal electron acceptor

O2, acetate, pyruvate

TAS [14]

MIGS-6

Habitat

Soil

TAS [14]

MIGS-15

Biotic relationship

Free-living

TAS [14]

MIGS-14

Pathogenicity

None; potential probiotic

NAS

 

Biosafety level

1

NAS

 

Isolation

Soil

TAS [14]

MIGS-4

Geographic location

Near Calistoga, California, USA

TAS [14]

MIGS-5

Sample collection time

2000

IDA

MIGS-4.1

Latitude

38.58 N

NAS

MIGS-4.2

Longitude

−122.58

NAS

MIGS-4.3

Depth

Surface

TAS [14]

MIGS-4.4

Altitude

351′

NAS

TAS, traceable author statement; IDA, inferred from direct assay; NAS, non-traceable author statement. These evidence codes are from the gene ontology project [31].

The B. coagulans group is polydisperse [12] and among the Bacillus spp., strain 36D1 is phylogenetically close to B. halodurans based on 16S rRNA(DNA) sequences (Fig. 2). Although B. coagulans is similar to lactic acid bacteria in its ability to grow anaerobically and ferment sugars to lactic acid, it is distinct from the lactic acid bacteria based on 16S rRNA(DNA) sequence similarity.
Figure 2.

Unrooted phylogenetic tree based on 16S rRNA(DNA) of B. coagulans strain 36D1 and Bacillus spp. and Lactobacillus spp.

Genome sequencing and annotation

Genome project history

This genome was selected for sequencing on the basis of the properties described above. The genome sequence is deposited in GenBank (Accession number, CP003056). Sequencing was initiated and completed to a level of four contigs and annotated by the DOE Joint Genome Institute (JGI). The original draft version was deposited in GenBank on February 7, 2007 and the final draft version with four contigs was deposited on Feb. 3, 2010, thereby updating previous releases to the database. Genome sequencing was completed at the University of Florida, annotated by the Oak Ridge National Laboratory, and processed by the Los Alamos National Laboratory and NCBI. A summary of the project information is shown in Table 2.
Table 2.

Genome sequencing project information

MIGS ID

Property

Term

MIGS-31

Finishing quality

Finished

MIGS-28

Libraries used

Genomic libraries: Sanger (one each of 2.5, 8 and 37 kbp library); one 454CT library (2 kb); PCR; primer walk

MIGS-29

Sequencing platforms

Sanger; 454

MIGS-31.2

Sequencing coverage

MIGS-30

Assemblers

Phrap, Newbler

MIGS-32

Gene calling method

Prodigal

 

Genome Database

GenBank

 

INSDC ID

CP003056

 

Genbank Date of Release

September 26, 2011

 

GOLD ID

GC01988

 

NCBI project ID

15679

MIGS-13

Source material identifier

ATCC PTA-5827

 

Project relevance

Biotechnological

Growth conditions and DNA isolation

B. coagulans strain 36D1 was cultured in LB + glucose (10 g/L) medium (pH 5.0) at 50°C in a shaker at 200 RPM as described before [10]. Cells were harvested during mid-exponential phase of growth. Cell pellet from a 30 ml culture was resuspended in 2.1 ml of TE buffer (Tris, 10 mM; EDTA, 10 mM; pH 8.0) supplemented with lysozyme (1 mg/ml; Sigma Chemical Co., St. Louis, MO, USA) and RNase (0.1 mg/ml; Sigma Chemical Co.). The sample was incubated at 37°C for 20 minutes to remove the cell wall. Sodium dodecyl sulfate (SDS) was added to the lysed cells to achieve an SDS concentration of 1.4%. After 10 minutes on ice, the lysate was extracted with equal volume of TE-saturated phenol to remove cellular debris. After two more extractions of the aqueous phase with equal volumes of phenol-chloroform mixture (25:24:1 of phenol, chloroform and isoamyl alcohol), and one extraction with an equal volume of chloroform:isoamyl alcohol, the DNA was precipitated with ethanol and dried. The ratio of absorbance at 260 nm and 280 nm of the purified DNA was 1.99 and based on agarose gel electrophoresis and ethidium bromide staining, DNA contained only a trace amount of degraded RNA.

Genome sequencing and assembly

The genome was sequenced using a combination of Sanger and 454 sequencing platforms. General aspects of library construction and sequencing can be found at the JGI website [32]. 454 pyrosequencing reads were assembled using the Newbler assembler version 1.1.02.15 (Roche). Large Newbler contigs were broken into 2 kb overlapping fragments (1 kb overlap) and entered into assembly as pseudo-reads. The sequences were assigned quality scores based on Newbler consensus q-scores with modifications to account for overlap redundancy and to adjust inflated q-scores. A hybrid 454/Sanger assembly was made using the Phrap assembler. Possible mis-assemblies were corrected with Dupfinisher or transposon bombing of bridging clones. Editing in Consed, custom primer walk or PCR amplification closed gaps between contigs. A total of 2,471 Sanger finishing reads were produced to close gaps, to resolve repetitive regions, and to raise the quality of the finished sequence. The error rate of the completed genome sequence was less than 1 in 100,000. Together all sequence types provided 9 x coverage of the genome. The final assembly contains a total of 35,357 Sanger and pyrosequence reads. This analysis yielded four contigs with lengths of 2,712, 65,471, 565,365 and 2,917,758 base pairs for a total of 3,551,306 base pairs.

In order to close the gaps, a restriction map of B. coagulans strain 36D1 genome was constructed using BglII restriction enzyme. This optical mapping by OpGen (Gaithersburg, MD) yielded a circular map of approximately 3,521 kbp. Comparing the computed restriction map of the DNA sequence from the four contigs with the restriction map of the whole genome, the lengths of the gaps between the appropriate contigs were predicted. Using the sequence information from the contigs and appropriate restriction fragments, PCR primers were synthesized and the genomic DNA was sequenced using Sanger method by the Interdisciplinary Center for Biotechnology Research at the University of Florida. As needed, PCR primers were synthesized based on new sequence information for genome walking to fill-in the gaps and complete the genome sequence. Based on these analyses, the genome of B. coagulans strain 36D1 was determined to be circular with a length of 3,552,226 base pairs.

Genome annotation

Genes were identified using Prodigal [33] as part of the Oak Ridge National Laboratory genome annotation pipeline. The predicted CDSs were translated and used to search the National Center for Biotechnology Information (NCBI) nonredundant database, UniProt, TIGRFam, Pfam, PRIAM, KEGG, COG, and InterPro databases. These data sources were combined to assert a product description for each predicted protein. Non-coding genes and miscellaneous features were predicted using tRNAscan-SE [34], RNAMMer [35], Rfam [36], TMHMM [37], and signalP [38].

Genome properties

The genome consists of a 3,552,226 bp long chromosome with a 46.5% GC content (Table 3, Fig. 3). Of the 3,420 genes predicted, 3,306 were protein coding genes, and 114 encode RNAs. Among the 114 RNA genes, 10 each coded for 5S, 16S and 23S rRNAs and 84 can be accounted for tRNAs.
Figure 3.

Graphical circular map of the genome of B. coagulans strain 36D1. From outside to center: Genes on forward strand (color by COG categories), Genes on reverse strand (color by COG categories), pseudogenes, % G+C, GC skew.

Table 3.

Genome statistics

Attribute

Value

% of total

Genome Size (bp)

3,552,226

100

DNA G+C content (bp)

1,651,327

46.5

Number of replicons

1

 

Extrachromosomal elements

0

 

Total genes

3420

100

RNA genes

114

3.3

Protein-coding genes

3306

96.7

Genes in paralog clusters

541

15.6

Genes assigned to COGs

2456

71.0

Genes with signal peptides

858

24.8

Genes with transmembrane helices

863

24.9

Paralogous groups

199

5.8

The majority of the protein-coding genes (74%) were assigned with a putative function while those remaining were annotated as hypothetical proteins. About 49 ORFs were identified as potential transposases. The distribution of genes into COGs functional categories is presented in Table 4. The first about 40% of the genome is predominantly transcribed from the lagging strand (as written) while the other 60% is transcribed from the leading strand (Fig. 4).
Figure 4.

Principal component analysis based on COG profiles

Table 4.

Number of genes associated with the general COG functional groups

Code

Value

%age

Description

J

172

5.14

Translation

A

0

0.00

RNA processing and modification

K

238

7.11

Transcription

L

144

4.30

Replication, recombination and repair

B

2

0.05

Chromatin structure and dynamics

D

106

3.16

Cell cycle control, mitosis and meiosis

Y

0

0.00

Nuclear structure

V

113

3.37

Defense mechanisms

T

162

4.84

Signal transduction mechanisms

M

240

7.17

Cell wall/membrane biogenesis

N

78

2.33

Cell motility

Z

0

0.00

Cytoskeleton

W

0

0.00

Extracellular structures

U

50

1.49

Intracellular trafficking and secretion

O

182

5.44

Posttranslational modification, protein turnover, chaperones

C

277

8.28

Energy production and conversion

G

310

9.26

Carbohydrate transport and metabolism

E

379

11.33

Amino acid transport and metabolism

F

100

2.98

Nucleotide transport and metabolism

H

217

6.48

Coenzyme transport and metabolism

I

104

3.10

Lipid transport and metabolism

P

214

6.39

Inorganic ion transport and metabolism

Q

168

5.02

Secondary metabolites biosynthesis, transport and catabolism

R

448

13.39

General function prediction only

S

242

7.23

Function unknown

-

  

Not in COGs (Total - 3345)

Insights from genome sequence

Comparison of the predicted proteome of B. coagulans with that of a group of Bacillus spp genomes identified 491 unique proteins in B. coagulans that are not identified in other members of Bacillus spp. 404 of these genes are in the early part of the 36D1 genome as listed. This list includes 31 genes encoding putative transposases. Function of many of these gene products is not known. However, 413 of these unique proteins are found to be shared with Lactobacillus spp. In reverse, comparison of the B. coagulans genome with the genomes from a group of Lactobacillus spp. revealed that 423 ORFs are unique to B. coagulans and of these, 345 ORFs, mostly related to sporulation, are shared with Bacillus spp. Combining these two sets, a set of 78 ORFs coding for proteins with unknown function are unique to B. coagulans that are not present in either Bacillus or Lactobacillus. Based on principal components analysis, B. coagulans strain 36D1 groups with Bacillus but as an outlier and away from Lactic acid bacteria (Fig. 4). Although B. coagulans produced L-lactic acid as the fermentation product at an optical purity reaching close to 100%, the genome contains a gene encoding D-LDH.

Although some members of B. coagulans group are cellulolytic and xylanolytic, strain 36D1 is phenotypically unable to utilize cellulose and xylan. However, genes encoding glycan hydrolases such as xylanase, xylosidase and α-amylase can be identified in the genome sequence. Presence of these genes suggest that the bacterium can be evolved to produce xylanase to reduce the severity of acid treatment during hydrolysis of hemicellulose from lignocellulosic biomass for production of optically pure lactic acid. B. coagulans strain 36D1 is an auxotroph for several amino acids and vitamins. Based on analysis of the genome sequence by Patric Comparative pathway tool [39], only histidine biosynthetic pathway appears to be incomplete among the amino acid biosynthesis pathways. Among the vitamins, the pathways for biosynthesis of biotin, pantothenic acid, nicotinamide and pyridoxine appear to be incomplete.

During the time of preparation of this manuscript, genome sequence for B. coagulans strain 2–6 was published [40]. The genome of this strain is 3,073,079 and is 479,147 bp smaller than the genome of strain 36D1. These two B. coagulans genomes share about 90% or higher nucleotide sequence identity in the regions that are present in both genomes. Additional comparative analysis of the two genomes is in progress.

Notes

Declarations

Acknowledgements

This study was supported in part by a grant from the Department of Energy (DE-FG36-04GO14019 and DE-FG36-08GO88142), US Department of Agriculture, National Institute of Food and Agriculture (2011-10006-30358), the State of Florida, University of Florida Agricultural Experiment Station and Florida Energy Systems Consortium. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.

Authors’ Affiliations

(1)
Department of Microbiology and Cell Science, University of Florida
(2)
Bioscience Division, Los Alamos National Laboratory
(3)
Joint Genome Institute
(4)
Oak Ridge National Laboratory

References

  1. Datta R, Henry M. Lactic acid: recent advances in products, processes and technologies — a review. J Chem Technol Biotechnol 2006; 81:1119–1129. doi:10.1002/jctb.1486View ArticleGoogle Scholar
  2. Madhavan NK, Nair NR, John RP. An overview of the recent developments in polylactide (PLA) research. Bioresour Technol 2010; 101:8493–8501. PubMed doi:10.1016/j.biortech.2010.05.092View ArticleGoogle Scholar
  3. Wee Y, Kim J, Ryu H. Biotechnological production of lactic acid and its recent applications. Food Technol Biotechnol 2006; 44:163–172.Google Scholar
  4. Hofvendahl K, Hans-Hagerdal B. Factors affecting the fermentative lactic acid production from renewable resources. Enzyme Microb Technol 2000; 26:87–107. PubMed doi:10.1016/S0141-0229(99)00155-6View ArticlePubMedGoogle Scholar
  5. Carole TM, Pellegrino J, Paster MD. Opportunities in the industrial biobased products industry. Appl Biochem Biotechnol 2004; 115:871–885. PubMed doi:10.1385/ABAB:115:1-3:0871View ArticleGoogle Scholar
  6. Mooney BP. The second green revolution? Production of plant-based biodegradable plastics. Biochem J 2009; 418:219–232. PubMed doi:10.1042/BJ20081769View ArticlePubMedGoogle Scholar
  7. Abe S, Takagi M. Simultaneous saccharification and fermentation of cellulose to lactic acid. Biotechnol Bioeng 1991; 37:93–96. PubMed doi:10.1002/bit.260370113View ArticlePubMedGoogle Scholar
  8. Iyer PV, Lee YY. Product inhibition in simultaneous saccharification and fermentation of cellulose into lactic acid. Biotechnol Lett 1999; 21:371–373. doi:10.1023/A:1005435120978View ArticleGoogle Scholar
  9. Ou MS, Mohammed N, Ingram LO, Shanmugam KT. Thermophilic Bacillus coagulans requires less cellulases for simultaneous saccharification and fermentation of cellulose to products than mesophilic microbial biocatalysts. Appl Biochem Biotechnol 2009; 155:379–385. PubMed doi:10.1007/s12010-008-8509-4PubMedGoogle Scholar
  10. Patel MA, Ou M, Ingram LO, Shanmugam KT. Simultaneous saccharification and co-fermentation of crystalline cellulose and sugar cane bagasse hemicellulose hydrolysate to lactate by a thermotolerant acidophilic Bacillus sp. Biotechnol Prog 2005; 21:1453–1460. PubMed doi:10.1021/bp0400339View ArticlePubMedGoogle Scholar
  11. Leber J. Economics improve for first commercial cellulosic ethanol plants. New York Times 2010:Feb. 16, 2010.
  12. De Clerck E, Rodriguez-Diaz M, Forsyth G, Lebbe L, Logan NA, DeVos P. Polyphasic characterization of Bacillus coagulans strains, illustrating heterogeneity within this species, and emended description of the species. Syst Appl Microbiol 2004; 27:50–60. PubMed doi:10.1078/0723-2020-00250View ArticlePubMedGoogle Scholar
  13. Ou MS, Ingram LO, Shanmugam KT. L: (+)-Lactic acid production from non-food carbohydrates by thermotolerant Bacillus coagulans. J Ind Microbiol Biotechnol 2011; 38:599–605. PubMed doi:10.1007/s10295-010-0796-4View ArticlePubMedGoogle Scholar
  14. Patel MA, Ou MS, Harbrucker R, Aldrich HC, Buszko ML, Ingram LO, Shanmugam KT. Isolation and characterization of acid-tolerant, thermophilic bacteria for effective fermentation of biomassderived sugars to lactic acid. Appl Environ Microbiol 2006; 72:3228–3235. PubMed doi:10.1128/AEM.72.5.3228-3235.2006PubMed CentralView ArticlePubMedGoogle Scholar
  15. Abdel-Banat BMA, Hoshida H, Ano A, Nonklang S, Akada R. High-temperature fermentation: how can processs for ethanol production at high temperatures become superior to the traditional process using mesophilic yeast? Appl Microbiol Biotechnol 2010; 85:861–867. PubMed doi:10.1007/s00253-009-2248-5View ArticlePubMedGoogle Scholar
  16. Drago L, De Vecchi E. Should Lactobacillus sporogenes and Bacillus coagulans have a future? J Chemother 2009; 21:371–377. PubMedView ArticlePubMedGoogle Scholar
  17. Kovács AT, van Hartskamp M, Kuipers OP, van Kranenburg R. Genetic tool development for a new host for biotechnology, the thermotolerant bacterium Bacillus coagulans. Appl Environ Microbiol 2010; 76:4085–4088. PubMed doi:10.1128/AEM.03060-09PubMed CentralView ArticlePubMedGoogle Scholar
  18. Rhee MS, Kim JW, Qian Y, Ingram LO, Shanmugam KT. Development of plasmid vector and electroporation condition for gene transfer in sporogenic lactic acid bacterium, Bacillus coagulans. Plasmid 2007; 58:13–22. PubMed doi:10.1016/j.plasmid.2006.11.006View ArticlePubMedGoogle Scholar
  19. Hammer BW. Bacteriological studies on the coagulation of evaporated milk. Iowa Agric. Exp. Station Res. Bull. 1915; 19:119–131.Google Scholar
  20. Woese CR, Kandler O, Wheelis ML. Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci USA 1990; 87:4576–4579. PubMed doi:10.1073/pnas.87.12.4576PubMed CentralView ArticlePubMedGoogle Scholar
  21. Gibbons NE, Murray RGE. Proposals Concerning the Higher Taxa of Bacteria. Int J Syst Bacteriol 1978; 28:1–6. doi:10.1099/00207713-28-1-1View ArticleGoogle Scholar
  22. Garrity GM, Holt JG. The Road Map to the Manual. In: Garrity GM, Boone DR, Castenholz RW (eds), Bergey’s Manual of Systematic Bacteriology, Second Edition, Volume 1, Springer, New York, 2001, p. 119–169.View ArticleGoogle Scholar
  23. Murray RGE. The Higher Taxa, or, a Place for Everything…? In: Holt JG (ed), Bergey’s Manual of Systematic Bacteriology, First Edition, Volume 1, The Williams and Wilkins Co., Baltimore, 1984, p. 31–34.Google Scholar
  24. List Editor. List of new names and new combinations previously effectively, but not validly, published. List No. 132. Int J Syst Evol Microbiol 2010; 60:469–472. doi:10.1099/ijs.0.022855-0
  25. Ludwig W, Schleifer KH, Whitman WB. Class I. Bacilli class nov. In: De Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer KH, Whitman WB (eds), Bergey’s Manual of Systematic Bacteriology, Second Edition, Volume 3, Springer-Verlag, New York, 2009, p. 19–20.Google Scholar
  26. Skerman VBD, McGowan V, Sneath PHA. Approved Lists of Bacterial Names. Int J Syst Bacteriol 1980; 30:225–420. doi:10.1099/00207713-30-1-225View ArticleGoogle Scholar
  27. Prévot AR. In: Hauderoy P, Ehringer G, Guillot G, Magrou J., Prévot AR, Rosset D, Urbain A (eds), Dictionnaire des Bactéries Pathogènes, Second Edition, Masson et Cie, Paris, 1953, p. 1–692.Google Scholar
  28. Fischer A. Untersuchungen über bakterien. Jahrbücher für Wissenschaftliche Botanik 1895; 27:1–163.Google Scholar
  29. Cohn F. Untersuchungen über Bakterien. Beitr Biol Pflanz 1872; 1:127–224.Google Scholar
  30. Gibson T, Gordon RE. Genus I. Bacillus Cohn 1872, 174; Nom. gen. cons. Nomencl. Comm. Intern. Soc. Microbiol. 1937, 28; Opin. A. Jud. Comm. 1955, 39. In: Buchanan RE, Gibbons NE (eds), Bergey’s Manual of Determinative Bacteriology, Eighth Edition, The Williams and Wilkins Co., Baltimore, 1974, p. 529–550.Google Scholar
  31. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25:25–29. PubMed doi:10.1038/75556PubMed CentralView ArticlePubMedGoogle Scholar
  32. The DOE Joint Genome tute. http://www.jgi.doe.gov.
  33. Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW, Hauser LJ. Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics 2010; 11:119. PubMed doi:10.1186/1471-2105-11-119PubMed CentralView ArticlePubMedGoogle Scholar
  34. Lowe TM, Eddy SR. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res 1997; 25:955–964. PubMed doi:10.1093/nar/25.5.955PubMed CentralView ArticlePubMedGoogle Scholar
  35. Lagesen K, Hallin P, Rodland EA, Staerfeldt HH, Rognes T, Ussery DW. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res 2007; 35:3100–3108. PubMed doi:10.1093/nar/gkm160PubMed CentralView ArticlePubMedGoogle Scholar
  36. Griffiths-Jones S, Bateman A, Marshall M, Khanna A, Eddy SR. Rfam: an RNA family database. Nucleic Acids Res 2003; 31:439–441. PubMed doi:10.1093/nar/gkg006PubMed CentralView ArticlePubMedGoogle Scholar
  37. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001; 305:567–580. PubMed doi:10.1006/jmbi.2000.4315View ArticlePubMedGoogle Scholar
  38. Bendtsen JD, Nielsen H, von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004; 340:783–795. PubMed doi:10.1016/j.jmb.2004.05.028View ArticlePubMedGoogle Scholar
  39. Patric Comparative pathway tool. http://www.patricbrc.org/portal/portal/patric/Path wayFinder?cType=taxon&cld=&dm=
  40. Su F, Yu B, Sun J, Ou HY, Zhao B, Wang L, Qin J, Tang H, Tao F, Jarek M, et al. Genome sequence of the thermophilic strain Bacillus coagulans 2–6, an efficient producer of high-optical-purity L-lactic acid. J Bacteriol 2011; 193:4563–4564. PubMed doi:10.1128/JB.05378-11PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2011